|
|
|
Insider
Information: |
Schlossberg Mark A |
Relationship: |
SVP - Legal & General ... |
City: |
Hayward |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
103,408 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,458,908 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
103,408 |
|
|
Total
Value |
$5,458,908 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
12.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Impax Laboratories Inc |
IPXL |
SVP and General Counsel |
2018-05-04 |
0 |
2011-07-08 |
0 |
Premium* |
|
Cytokinetics Inc |
CYTK |
SVP - Legal & General ... |
2022-03-15 |
103,408 |
2020-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2013-05-23 |
4 |
D |
$18.60 |
$14,787 |
D/D |
(795) |
60,921 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2014-05-23 |
4 |
D |
$27.89 |
$22,730 |
D/D |
(815) |
78,024 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2013-03-12 |
4 |
B |
$16.73 |
$16,728 |
D/D |
1,000 |
36,916 |
2.74 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2016-05-23 |
4 |
D |
$32.12 |
$35,171 |
D/D |
(1,095) |
87,921 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2015-05-23 |
4 |
D |
$46.21 |
$50,923 |
D/D |
(1,102) |
89,610 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2016-02-26 |
4 |
D |
$33.27 |
$64,244 |
D/D |
(1,931) |
71,657 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2015-05-14 |
4 |
D |
$44.82 |
$96,946 |
D/D |
(2,163) |
93,042 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2016-05-14 |
4 |
D |
$29.18 |
$63,116 |
D/D |
(2,163) |
91,346 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2014-05-15 |
4 |
D |
$25.56 |
$59,555 |
D/D |
(2,330) |
78,839 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2015-05-15 |
4 |
D |
$44.44 |
$103,545 |
D/D |
(2,330) |
90,712 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2016-05-15 |
4 |
D |
$29.18 |
$67,989 |
D/D |
(2,330) |
89,016 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2012-07-08 |
4 |
D |
$20.25 |
$55,708 |
D/D |
(2,751) |
35,916 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2013-07-08 |
4 |
D |
$20.33 |
$55,951 |
D/D |
(2,752) |
58,169 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2014-07-08 |
4 |
D |
$28.80 |
$81,187 |
D/D |
(2,819) |
75,205 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2017-05-14 |
4 |
D |
$17.65 |
$57,098 |
D/D |
(3,235) |
101,944 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2018-03-02 |
4 |
D |
$19.50 |
$63,824 |
D/D |
(3,273) |
89,246 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
|
2022-03-02 |
4 |
D |
$37.63 |
$130,087 |
D/D |
(3,457) |
52,418 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2017-05-15 |
4 |
D |
$16.80 |
$58,598 |
D/D |
(3,488) |
98,456 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2015-07-08 |
4 |
D |
$45.99 |
$180,097 |
D/D |
(3,916) |
85,694 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
|
2021-03-08 |
4 |
D |
$19.19 |
$79,639 |
D/D |
(4,150) |
50,850 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
|
2022-03-07 |
4 |
D |
$36.83 |
$170,560 |
D/D |
(4,631) |
67,787 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2015-08-27 |
4 |
S |
$43.41 |
$201,813 |
D/D |
(4,649) |
81,045 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
SVP - Legal & General Counsel |
|
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,025 |
55,875 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2018-02-26 |
4 |
D |
$20.95 |
$124,380 |
D/D |
(5,937) |
92,519 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
SVP and General Counsel |
|
2017-02-26 |
4 |
D |
$14.05 |
$84,497 |
D/D |
(6,014) |
81,907 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|